tradingkey.logo

Nuwellis Inc

NUWE
3.750USD
-0.100-2.60%
Fechamento 02/02, 16:00ETCotações atrasadas em 15 min
5.12MValor de mercado
0.02P/L TTM

Mais detalhes de Nuwellis Inc Empresa

Nuwellis, Inc. is a commercial-stage medical technology company. The Company is focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems (collectively the Aquadex System). The Aquadex SmartFlow system is indicated for temporary or extended use in adult and pediatric patients weighing 20 kilograms or more whose fluid overload is unresponsive to medical management, including diuretics. The Aquadex System is designed to remove excess fluid from patients suffering from fluid overload who have failed diuretic therapy. The Aquadex System consists of a console, which is a piece of equipment containing electromechanical pumps and a liquid crystal display (LCD) screen; a one-time disposable blood circuit set, which is an integrated collection of tubing, filters, sensors, and connectors that contain and deliver the blood from and back to the patient, and a disposable catheter.

Informações de Nuwellis Inc

Código da empresaNUWE
Nome da EmpresaNuwellis Inc
Data de listagemFeb 16, 2012
CEOErb (John L)
Número de funcionários38
Tipo de títulosOrdinary Share
Fim do ano fiscalFeb 16
Endereço12988 Valley View Rd
CidadeEDEN PRAIRIE
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal55344
Telefone19523454200
Sitehttps://www.nuwellis.com/
Código da empresaNUWE
Data de listagemFeb 16, 2012
CEOErb (John L)

Executivos da empresa Nuwellis Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Erb (John L)
Erb (John L)
Chairman of the Board, President, Chief Executive Officer, Interim Chief Financial Officer, Interim Principal Financial Officer and Interim Principal Accounting Officer
Chairman of the Board, President, Chief Executive Officer, Interim Chief Financial Officer, Interim Principal Financial Officer and Interim Principal Accounting Officer
803.00
+803.00%
Dr. Archelle (Feldshon) Georgiou, M.D.
Dr. Archelle (Feldshon) Georgiou, M.D.
Independent Director
Independent Director
3.00
+3.00%
Mr. Gregory D. (Greg) Waller
Mr. Gregory D. (Greg) Waller
Independent Director
Independent Director
--
--
Dr. Maria Rosa Costanzo, M.D.
Dr. Maria Rosa Costanzo, M.D.
Independent Director
Independent Director
--
--
Mr. Neil P. Ayotte, Esq.
Mr. Neil P. Ayotte, Esq.
Senior Vice President, General Counsel, Secretary and Chief Compliance Officer
Senior Vice President, General Counsel, Secretary and Chief Compliance Officer
--
--
Mr. Michael (Mike) Mccormick
Mr. Michael (Mike) Mccormick
Lead Independent Director
Lead Independent Director
--
--
Mr. David Alan (Dave) Mcdonald
Mr. David Alan (Dave) Mcdonald
Independent Director
Independent Director
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Erb (John L)
Erb (John L)
Chairman of the Board, President, Chief Executive Officer, Interim Chief Financial Officer, Interim Principal Financial Officer and Interim Principal Accounting Officer
Chairman of the Board, President, Chief Executive Officer, Interim Chief Financial Officer, Interim Principal Financial Officer and Interim Principal Accounting Officer
803.00
+803.00%
Dr. Archelle (Feldshon) Georgiou, M.D.
Dr. Archelle (Feldshon) Georgiou, M.D.
Independent Director
Independent Director
3.00
+3.00%
Mr. Gregory D. (Greg) Waller
Mr. Gregory D. (Greg) Waller
Independent Director
Independent Director
--
--
Dr. Maria Rosa Costanzo, M.D.
Dr. Maria Rosa Costanzo, M.D.
Independent Director
Independent Director
--
--
Mr. Neil P. Ayotte, Esq.
Mr. Neil P. Ayotte, Esq.
Senior Vice President, General Counsel, Secretary and Chief Compliance Officer
Senior Vice President, General Counsel, Secretary and Chief Compliance Officer
--
--
Mr. Michael (Mike) Mccormick
Mr. Michael (Mike) Mccormick
Lead Independent Director
Lead Independent Director
--
--

Detalhamento da receita

Os dados relevantes ainda não foram divulgados pela empresa.
Os dados relevantes ainda não foram divulgados pela empresa.
Por Empresa
Por Região
Os dados relevantes ainda não foram divulgados pela empresa.

Distribuição de ações

Atualizado em: sex, 2 de jan
Atualizado em: sex, 2 de jan
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Sabby Management, LLC
5.41%
DRW Securities, LLC
2.14%
Bigger Capital Funds, LP
0.34%
Citi Investment Research (US)
0.13%
Tower Research Capital LLC
0.06%
Outro
91.93%
Investidores
Investidores
Proporção
Sabby Management, LLC
5.41%
DRW Securities, LLC
2.14%
Bigger Capital Funds, LP
0.34%
Citi Investment Research (US)
0.13%
Tower Research Capital LLC
0.06%
Outro
91.93%
Tipos de investidores
Investidores
Proporção
Investment Advisor/Hedge Fund
5.41%
Investment Advisor
2.18%
Hedge Fund
0.40%
Research Firm
0.13%
Individual Investor
0.02%
Outro
91.87%

Participação acionária institucional

Atualizado em: qui, 1 de jan
Atualizado em: qui, 1 de jan
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q4
20
134.31K
8.11%
+91.72K
2025Q3
18
13.52K
2.03%
+10.09K
2025Q2
27
9.97K
1.46%
+7.11K
2025Q1
26
140.31K
3.15%
+23.64K
2024Q4
25
113.78K
2.60%
+73.44K
2024Q3
29
65.32K
2.68%
+45.76K
2024Q2
28
42.02K
3.15%
+30.15K
2024Q1
26
9.25K
4.91%
+1.97K
2023Q4
26
6.22K
6.75%
+3.61K
2023Q3
35
1.28K
4.82%
-1.76K
Ver Mais

Atividade dos acionistas

Nome
Ações detidas
Proporção
Variação
Var. %
Data
Sabby Management, LLC
35.89K
2.16%
+32.37K
+918.85%
Sep 30, 2025
DRW Securities, LLC
36.08K
2.18%
+36.08K
--
Sep 30, 2025
Bigger Capital Funds, LP
5.69K
0.34%
+5.69K
--
Jun 09, 2025
Citi Investment Research (US)
1.15K
0.13%
+1.15K
--
Sep 30, 2025
Tower Research Capital LLC
1.03K
0.06%
+898.00
+680.30%
Sep 30, 2025
UBS Financial Services, Inc.
2.86K
0.17%
+979.00
+52.10%
Sep 30, 2025
Erb (John L)
803.00
0.02%
+803.00
--
Jun 10, 2025
SBI Securities Co., Ltd.
63.00
0%
+2.00
+3.28%
Sep 30, 2025
The Vanguard Group, Inc.
31.00
0%
--
--
Nov 30, 2025
BofA Global Research (US)
5.00
0%
+4.00
+400.00%
Sep 30, 2025
Ver Mais

ETFs Relacionados

Nome
Proporção
Sem dados

Dividendo

Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados

Desdobramento de ações

Data
Data ex-dividendo
Tipo
Proporção
Jul 02, 2025
Merger
42→1
Jun 26, 2024
Merger
35→1
Jun 26, 2024
Merger
35→1
Jun 26, 2024
Merger
35→1
Jun 26, 2024
Merger
35→1
Dec 09, 2022
Merger
100→1
Data
Data ex-dividendo
Tipo
Proporção
Jul 02, 2025
Merger
42→1
Jun 26, 2024
Merger
35→1
Jun 26, 2024
Merger
35→1
Jun 26, 2024
Merger
35→1
Jun 26, 2024
Merger
35→1
Dec 09, 2022
Merger
100→1
Dec 09, 2022
Merger
100→1
Dec 09, 2022
Merger
100→1
Dec 09, 2022
Merger
100→1
Oct 17, 2020
Merger
30→1
Ver Mais
KeyAI